Don't let your patients drown in the risks of dangerously high triglycerides

Severe hypertriglyceridemia (sHTG), defined by triglyceride levels ≥500 mg/dL, increases the risk of potentially life-altering events, including acute pancreatitis and atherosclerotic cardiovascular disease1

Triglyceride molecule illustration
Triglyceride
Actor portrayal. Not an actual patient.
Risk assessment icon

See how risks associated with severe hypertriglyceridemia (sHTG) vary depending on triglyceride level1

Explore risks Arrow right Arrow right hover
clipboard icon

Could your patient have familial chylomicronemia syndrome, a genetic form of sHTG?2

Calculate their clinical score Arrow right Arrow right hover

References

References

  1. Virani SS, Morris PB, Agarwala A, et al. 2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American College of Cardiology solution set oversight committee. J Am Coll Cardiol. 2021;78(9):960-993.
  2. D'Erasmo L, Di Costanzo A, Cassandra F, et al. Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes. Arterioscler Thromb Vasc Biol. 2019;39(12):2531-2541.